Longitudinal medication usage in Alzheimer disease patients.

Longitudinal medication usage in Alzheimer disease patients.

Item
http://www.wikidata.org/entity/Q30549920
Persistence and adherence with dementia pharmacotherapy: relevance of patient, provider, and system factorsUtilization of antihypertensives, antidepressants, antipsychotics, and hormones in Alzheimer disease.Effects of Food and Drug Administration-approved medications for Alzheimer's disease on clinical progressionLong-term associations between cholinesterase inhibitors and memantine use and health outcomes among patients with Alzheimer's diseaseCholinesterase inhibitor and memantine use in newly admitted nursing home residents with dementiaTreatment of Alzheimer's disease in Brazil: I. Cognitive disorders.The Predictors study: Development and baseline characteristics of the Predictors 3 cohort.Patterns and Determinants of Dementia Pharmacotherapy in a Population-Based Cohort of Home Care Clients
P2860

Longitudinal medication usage in Alzheimer disease patients.

Item
http://www.wikidata.org/entity/Q30549920
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Longitudinal medication usage in Alzheimer disease patients.
@ast
Longitudinal medication usage in Alzheimer disease patients.
@en
type
label
Longitudinal medication usage in Alzheimer disease patients.
@ast
Longitudinal medication usage in Alzheimer disease patients.
@en
prefLabel
Longitudinal medication usage in Alzheimer disease patients.
@ast
Longitudinal medication usage in Alzheimer disease patients.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Longitudinal medication usage in Alzheimer disease patients.
@en
P2093
P2860
P304
P31
P356
10.1097/WAD.0B013E3181E6A17A
P407
P433
P478
P50
P577
P698
P921
P932